TY  - JOUR
AU  - Los-Arcos, Ibai
AU  - Iacoboni, Gloria
AU  - Aguilar-Guisado, Manuela
AU  - Alsina-Manrique, Laia
AU  - Díaz de Heredia, Cristina
AU  - Fortuny-Guasch, Claudia
AU  - García-Cadenas, Irene
AU  - García-Vidal, Carolina
AU  - González-Vicent, Marta
AU  - Hernani, Rafael
AU  - Kwon, Mi
AU  - Machado, Marina
AU  - Martínez-Gómez, Xavier
AU  - Maldonado, Valentín Ortiz
AU  - Pla, Carolina Pinto
AU  - Piñana, José Luis
AU  - Pomar, Virginia
AU  - Reguera-Ortega, Juan Luis
AU  - Salavert, Miguel
AU  - Soler-Palacín, Pere
AU  - Vázquez-López, Lourdes
AU  - Barba, Pere
AU  - Ruiz-Camps, Isabel
PY  - 2020
DO  - 10.1007/s15010-020-01521-5
UR  - http://hdl.handle.net/10668/16319
T2  - Infection
AB  - Chimeric antigen receptor (CAR) T-cell therapy is one of the most promising emerging treatments for B-cell malignancies. Recently, two CAR T-cell products (axicabtagene ciloleucel and tisagenlecleucel) have been approved for patients with aggressive...
LA  - en
KW  - B-cell acute lymphoblastic leukemia
KW  - Bacterial infections
KW  - Chimeric antigen receptor
KW  - Diffuse large B-cell lymphoma
KW  - Fungal infections
KW  - Viral infections
KW  - Adult
KW  - Bacterial Infections
KW  - Child
KW  - Humans
KW  - Immunotherapy, Adoptive
KW  - Mycoses
KW  - Neoplasms
KW  - Risk Factors
KW  - T-Lymphocytes
KW  - Virus Diseases
TI  - Recommendations for screening, monitoring, prevention, and prophylaxis of infections in adult and pediatric patients receiving CAR T-cell therapy: a position paper.
TY  - research article
VL  - 49
ER  -